Unistar Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 10 Months
About Unistar Pharma
Unistar Pharma Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2023 (One year and ten months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Udaya Perla and Ravi Kollipora serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U21009TS2023PTC171397
-
Company No.
171397
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Mar 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Unistar Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udaya Perla
|
Director | 27-Mar-2023 | Current |
|
Ravi Kollipora
|
Director | 27-Mar-2023 | Current |
Financial Performance of Unistar Pharma.
Enhance accessibility to Unistar Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unistar Pharma?
Unlock access to Unistar Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Unicon Pharma Private LimitedUdaya Perla and Ravi Kollipora are mutual person
-
Agap Technologies Private LimitedRavi Kollipora is a mutual person
-
Sarath Meditech Private LimitedUdaya Perla is a mutual person
-
Layerly Pharmaceuticals Private Limited
Udaya Perla is a mutual person
-
Starus Pharmaceuticals Industries Private Limited
Udaya Perla is a mutual person
-
Spanus Pharmaceuticals Private Limited
Udaya Perla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unistar Pharma?
Unlock and access historical data on people associated with Unistar Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unistar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unistar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.